JPS6212720A - Production of aloe reishi - Google Patents

Production of aloe reishi

Info

Publication number
JPS6212720A
JPS6212720A JP60153147A JP15314785A JPS6212720A JP S6212720 A JPS6212720 A JP S6212720A JP 60153147 A JP60153147 A JP 60153147A JP 15314785 A JP15314785 A JP 15314785A JP S6212720 A JPS6212720 A JP S6212720A
Authority
JP
Japan
Prior art keywords
aloe
reishi
action
extract
vacuum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60153147A
Other languages
Japanese (ja)
Inventor
Yasahiro Morita
森田 弥三弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP60153147A priority Critical patent/JPS6212720A/en
Publication of JPS6212720A publication Critical patent/JPS6212720A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain aloe REISHI (Fomes japonicus), by extracting aloe which is a perennial indeciduous fleshy pland of Liliaceae family, impregnating the extract into various kind of REISHI under reduced pressure, packaging in vacuum and sterilizing the product. CONSTITUTION:Extract of Aloe arborescence, Aloe ferox, Aloe perryi or Aloe vera contains aloin, aloeemodin, aloetin, alomitin, aloeurucin, other carcinostatic substances, minerals, vitamins and various enzymes. The aloe extract is impregnated into Fomes japonicus (a fungus belonging to Polyporaceae family) (a whole fungus) under reduced pressure, packaged in vacuum and sterilized to obtain the objective aloe REISHI. An immunotherapeutic effect can be attained by the synergistic actions of the components and the health of human body can be promoted by the action of the polysaccharides in addition to the mental effect. The aloe REISHI has various actions such as sedative action, cardiotonic and hypotensive action, peripheral vessel dilation action and immuno-enhancing action to cancer cell, etc.

Description

【発明の詳細な説明】 この発明は、アロエ中の薬効成分、アロイン、アロエエ
モジン、アロエチン、アロミチン、アロエウルシン、ソ
の他抗癌物質、ミネラル、ビタミン、各種酵素を含有す
るアロエエキスをサルノコシカケ科のマンネンタケ(姿
のままの霊芝)の中に真空含浸することにより、アロエ
、霊芝の薬効の相乗効果及免疫療法の必須条件である。
DETAILED DESCRIPTION OF THE INVENTION This invention utilizes an aloe extract containing medicinal components of aloe, aloin, aloe emodin, aloetin, allomitin, aloe ursin, anticancer substances, minerals, vitamins, and various enzymes, from the medicinal ingredients of aloe Vacuum infiltration into ganoderma (reishi in its original form) creates a synergistic effect between the medicinal properties of aloe and ganoderma, which is an essential condition for immunotherapy.

多糖体及精神的な影壱を利用した人間の生体の健康を目
的とした発明である。
This invention aims to improve the health of the human body by utilizing polysaccharides and mental effects.

霊芝の成分としては、解明されているものだけを明記し
よう。解明出来ていないものが数多くあることは、薬効
の面からも多数あることは判断出来るが明記出来ないこ
とが残念である。
As for the ingredients of Reishi mushroom, I will only list those that have been elucidated. The fact that there are many things that have not yet been elucidated can be judged from the standpoint of medicinal efficacy, but it is unfortunate that it cannot be specified clearly.

霊芝の成分は、工〃ゴスチロール、リルイン酸、フマー
ル酸、有機酸、アミノブドー糖、多糖類、樹脂、アンニ
トール1脂肪酸、アルカロイド、ラクトン水溶性蛋白、
各種の酵素(エステヲーゼ、リパーゼ、レシチナーゼ、
ペタターゼ、アミグダラーゼ、リグニナーゼ、パーオキ
シダーゼ。
The ingredients of Ganoderma include gostyrol, lyluic acid, fumaric acid, organic acids, aminobutose, polysaccharides, resins, annitol monofatty acid, alkaloids, lactone water-soluble protein,
Various enzymes (esthesis, lipase, lecithinase,
Petatase, amygdalase, ligninase, peroxidase.

ラフカーゼ、フマラーゼ、カタラーゼ、ルチフェラーゼ
roughcase, fumarase, catalase, luciferase.

リチ二ナーゼ、フェノラーゼ、タンナーゼ、サッカラー
ゼ。
Litinase, phenolase, tannase, saccharase.

インベルターゼ、マルターゼ、トレパラーゼ、セルラー
ゼ。
invertase, maltase, trepalase, cellulase.

セロビアーゼ、チターゼ+Bt−3グルカナーゼ、ヘミ
セル    □ラーゼ、ジャスターゼ、アミラーゼ、イ
ヌラーゼ、ラフィナーゼ、グ〃コシダーゼ、エムルシン
、キチナーゼ、チマーゼ、ギコラーゼ、レンニン、ヘテ
シン、ツリプシン、ニレプシン、アスパラギナーゼ、チ
ロシナーゼ、ウレアーゼ)A、アロエ霊芝の薬理作用 ■ 中枢神経系では、M静作用(鎮痛作用)■ 循環系
に対する作用として強心作用と血圧降下作用■ 末梢血
管の拡張 ■ ガン細胞に対して免疫を高める ■ アロエチンにはグラム陰性菌(大腸菌、緑膿菌など
)グラム陰性菌(ブドウ球菌、肺炎菌、連鎖球菌)糸状
菌の発育を阻止し、殺す働きがあります。
Cellobiase, titase + Bt-3 glucanase, hemicell □rase, justase, amylase, inulase, raffinase, glucosidase, emulsin, chitinase, chymase, gycolase, rennin, hetesin, thuripsin, nilepsin, asparaginase, tyrosinase, urease) A, Aloe spirit Pharmacological effects of grass■ In the central nervous system, M-static effect (analgesic effect)■ In the circulatory system, it has cardiotonic and hypotensive effects■ Dilation of peripheral blood vessels■ Increases immunity against cancer cells■ Aloetin contains Gram-negative bacteria It has the effect of inhibiting the growth of filamentous bacteria (E. coli, Pseudomonas, etc.), Gram-negative bacteria (Staphylococcus, Streptococcus pneumoniae, Streptococcus), and killing them.

■ アロエチン、アロミチンに上記の菌が出す毒素を中
和する働きがあります。
■ Aloetin and aromitin have the ability to neutralize the toxins produced by the above bacteria.

■ アロエウルシンには胃潰瘍や十二指腸潰瘍をいやす
作用がある。
■ Aloe ursin has the effect of healing gastric and duodenal ulcers.

■ 肝臓の保護及びその他の作用として耐受酵素欠乏能
力を高めることが出来る。
■ As liver protection and other effects, it can enhance the ability to tolerate enzyme deficiency.

■ 呼吸系統に対する作用として慢性気管支炎に対して
気管支膜上皮の修復作用を促進する。
■ As an effect on the respiratory system, it promotes the repair action of the bronchial membrane epithelium in chronic bronchitis.

[相] アロイン、アロエエモジンは隔壁に刺激を与え
て、腸のぜん動を促し、正常な排便をします。
[Phase] Aloin and aloe-emodin stimulate the septum, promoting intestinal peristalsis and normal defecation.

B、ガン細胞に対する免疫効果の検定は移植癌を問題に
せず。
B. Testing of the immune effect on cancer cells does not concern transplanted cancer.

自然発生癌を対照にした。Spontaneous cancer was used as a control.

■ アロエ霊芝を投与したネコ群と投与しないネコ群を
ガンウィルスに自然感染させることにより、白血病にが
がる率を調査した。試験ネコはフォクマ抗体を血液中に
もたないネコを集め、隔離繁殖させ、十匹をA群とし、
十匹をB群とし隔離し、A群にはアロエ霊芝をアルカリ
イオン水にて煎出、10C03回飲用1食餌はA群には
、麦飯。
■ We investigated the incidence of leukemia by naturally infecting a group of cats treated with Aloe Reishi and a group of cats not treated with a cancer virus. The test cats were those that did not have Fokuma antibodies in their blood, were isolated and bred, and 10 cats were grouped into Group A.
Ten animals were isolated as group B, and group A was given aloe reishi decoction in alkaline ionized water. Group A was given barley rice after drinking 10C03 times.

イリコ、ワカメの味噌汁(飲料水、調理水はすべてアル
カリイオン水)又、B群には牛乳、肉を主食とし、米飯
を副食とした飲料水は水道水とした。
Miso soup with iriko and wakame (drinking water and cooking water were all alkaline ionized water); Group B had milk and meat as their staple food, and had cooked rice as a side dish; the drinking water was tap water.

6ケ月飼育の後、フォクマ抗体を持ったネコ5匹を両群
中に入れるにB群のネコは10日後、血液検査により(
ギムザ染色)白血病と診断した。
After 6 months of breeding, 5 cats with Fokma antibodies were included in both groups.The cats in group B were found to have blood tests after 10 days (
The patient was diagnosed with leukemia (Giemsa staining).

発病後7日〜10日にて、10匹共死亡した。All 10 animals died 7 to 10 days after onset of the disease.

A群は一匹も発病しなかった。しかし、抗体を発見する
血液中にフォクマ抗体を発見したことは、A群lO匹白
血病にかかったが9発病しなかったことを意味する。
None of the animals in group A became ill. However, the discovery of Fokma antibodies in the blood that detected antibodies means that although 10 animals in Group A had leukemia, they did not develop the disease.

■ 肺癌患者に投与 55才 男性 右肺上葉を切除、リンパ節転移のため抗
癌剤の投与を一本静脈注射するに副作用強く、中止。
■ Administered to a patient with lung cancer 55-year-old male The upper lobe of the right lung was removed, and due to lymph node metastasis, administration of an anticancer drug was discontinued due to strong side effects after intravenous injection.

アロエ霊芝、椎茸霊芝9食事療法により全治。Fully cured with aloe reishi, shiitake mushroom reishi 9 diet therapy.

■ 肺癌  右肺癌 切開不能のため、放射線治療、抗癌剤治療、先山ワクチ
ン治療、副作用強力のため、すべて中止、アロエ霊芝 
     □椎茸霊芝9禽事療法のみにて三年間延命中
。           1■ 肺癌、右肺5葉除去 
50才 男性手術後輸血によりウィルス性肝炎を併発、
安静療法を行い、病院を3ケ所変えるも治癒しないため
アロエ霊芝。
■ Lung cancer Radiation therapy, anti-cancer drug treatment, Sakiyama vaccine treatment, all canceled due to strong side effects due to incision of right lung cancer, Aloe Reishi
□His life has been extended for three years using only Shiitake mushroom and Reishi therapy. 1■ Lung cancer, removal of 5 lobes of right lung
A 50-year-old man developed viral hepatitis due to blood transfusion after surgery.
Although I received rest therapy and changed hospitals to three different hospitals, I was not cured, so I tried Aloe Reishi.

椎茸霊芝9食事療法を行う。現在4年延命■ 胃癌 8
4才 女性 10年前切開除去手術後食欲なく、骨と皮
の状態が6ケ月続いたが、アロエ霊芝、椎茸霊芝1食事
療法により現在全治■ 其の他500人の治験例あるも
すべて手術、放射線、抗癌剤、免疫療法と併用したもの
である。
Perform Shiitake Mushroom Reishi 9 Diet Therapy. Currently living 4 years longer ■ Stomach cancer 8
4-year-old female After incisional removal surgery 10 years ago, she lost her appetite and had a bone and skin condition for 6 months, but she is now completely cured with a diet of aloe vera, shiitake mushroom, and 1 diet. It is used in combination with surgery, radiation, anticancer drugs, and immunotherapy.

治験例60チ(効率)化学療法の副作用による死亡と判
断出来るものが多い。
60 cases of clinical trials (efficiency) Many of the deaths were determined to be due to side effects of chemotherapy.

C,アロエ霊芝の効力 ■ ガン細胞に対する免疫を高める多糖体による免疫と
共に高貴薬霊芝の姿による精神的影響により免疫を高め
る。
C. Efficacy of Aloe Reishi■ It enhances immunity through polysaccharides that increase immunity against cancer cells, as well as the psychological influence of the appearance of the noble medicine Reishi.

■ 中性脂肪の顕著な減少 中性脂肪 正常値54−155であるが2320人が3
ケ月飲用し135になった。
■ Significant decrease in triglyceride The normal value of triglyceride is 54-155, but 2,320 people had 3
I drank it every month and got to 135.

■ 本態性高血圧の降下正常値上14(+下80である
が、上180下10Gの人が2週間後止140下80に
なった。
■ Decrease in essential hypertension The normal value is upper 14 (+ lower 80), but a person with upper 180 and lower 10 G stopped dropping to 140 and lower 80 after two weeks.

■ 肝炎治験例効果率は98チであった。■ Efficacy rate for hepatitis trials was 98.

■ 糖尿病治験例効果率は901%であった。■ Diabetic trial case efficacy rate was 901%.

■ 慢性気管支炎治験例効果率は98チであった。■ Chronic bronchitis trial case efficacy rate was 98.

■ 狭心症治験例効果率は90%であった。■ Efficacy rate in clinical trials for angina pectoris was 90%.

■ 神経衰弱治験例効果率は98%であった。■ Efficacy rate in neurasthenia clinical trials was 98%.

■ アレルギー全般治験例効果率70チ。■ General allergy clinical trial efficacy rate of 70.

[相] 水嵩症(腎臓機能不全)治験例少いが90チ■
 胃及十二指腸潰瘍治験例効果率90%O慢性関節リウ
マチ3人中3人とも効果あり0 原因不明の便秘治験例
効果率100%0 脳卒中予防 ■ ノイローゼや不眠に効果 [相] 女性の肌荒れ、シミ、ソバカスに効果お血を解
消する秀れた浄血作用による @ 血栓症に効果 お血や血栓を防ぐ作用がある。
[Phase] Hydraulic syndrome (kidney dysfunction) clinical trial cases are few, but 90 cases ■
Efficacy rate in clinical trials for gastric and duodenal ulcers: 90% O Rheumatoid arthritis Effective in 3 out of 3 patients 0 Efficacy in trial cases with unexplained constipation 100% 0 Stroke prevention ■ Effective for neurosis and insomnia [Phase] Rough skin and age spots in women , effective against freckles, due to its excellent blood-purifying action that eliminates blood clots. Effective against thrombosis: has the effect of preventing blood clots and blood clots.

0 心筋梗塞に効果 0 動脈硬化に効果 の 低血圧の正常化0 Effective against myocardial infarction 0 Effective against arteriosclerosis Normalization of hypotension

Claims (1)

【特許請求の範囲】[Claims] ユリ科の多年生常緑多肉質草本であるキダチアロエ、ケ
ープアロエ、ソコトラアロエ、キュラソーアロエより得
たエキスを種々の霊芝中に真空含浸し、真空包装、滅菌
したアロエ霊芝の製造法
A method for producing Aloe Reishi by vacuum-impregnating extracts from Kidachi Aloe, Cape Aloe, Socotra Aloe, and Curacao Aloe, which are perennial evergreen succulent herbs of the Liliaceae family, into various Reishi mushrooms, vacuum packaging, and sterilization.
JP60153147A 1985-07-10 1985-07-10 Production of aloe reishi Pending JPS6212720A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60153147A JPS6212720A (en) 1985-07-10 1985-07-10 Production of aloe reishi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60153147A JPS6212720A (en) 1985-07-10 1985-07-10 Production of aloe reishi

Publications (1)

Publication Number Publication Date
JPS6212720A true JPS6212720A (en) 1987-01-21

Family

ID=15556042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60153147A Pending JPS6212720A (en) 1985-07-10 1985-07-10 Production of aloe reishi

Country Status (1)

Country Link
JP (1) JPS6212720A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06116162A (en) * 1992-10-06 1994-04-26 Toyo Seiyaku Kk Antibacterial agent against staphylococcus
JPH06116161A (en) * 1992-10-06 1994-04-26 Toyo Seiyaku Kk Antibacterial agent against streptococcus
WO1999038519A1 (en) * 1998-01-30 1999-08-05 Ivan Gorgiev Anticancer composition
KR100899220B1 (en) 2007-11-16 2009-05-26 (주)휴럼 Fermented Aloe and Manufacturing Method of Fermented Aloe and Functional food of Thereof Manufacturing
WO2009121058A1 (en) * 2008-03-28 2009-10-01 Novozymes A/S Producing fermentation products in the presence of trehalase
WO2012010593A1 (en) * 2010-07-21 2012-01-26 Novozymes A/S Process for producing a baked product having increased flavor stability with catalase and phospholipase
JP2013539358A (en) * 2010-07-14 2013-10-24 ネステク ソシエテ アノニム Asparaginase from basidiomycetes

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06116162A (en) * 1992-10-06 1994-04-26 Toyo Seiyaku Kk Antibacterial agent against staphylococcus
JPH06116161A (en) * 1992-10-06 1994-04-26 Toyo Seiyaku Kk Antibacterial agent against streptococcus
WO1999038519A1 (en) * 1998-01-30 1999-08-05 Ivan Gorgiev Anticancer composition
KR100899220B1 (en) 2007-11-16 2009-05-26 (주)휴럼 Fermented Aloe and Manufacturing Method of Fermented Aloe and Functional food of Thereof Manufacturing
WO2009121058A1 (en) * 2008-03-28 2009-10-01 Novozymes A/S Producing fermentation products in the presence of trehalase
JP2013539358A (en) * 2010-07-14 2013-10-24 ネステク ソシエテ アノニム Asparaginase from basidiomycetes
US9410138B2 (en) 2010-07-14 2016-08-09 Nestec S.A. Asparaginase from basidiomycetes
WO2012010593A1 (en) * 2010-07-21 2012-01-26 Novozymes A/S Process for producing a baked product having increased flavor stability with catalase and phospholipase

Similar Documents

Publication Publication Date Title
CN101624570B (en) Method for cultivating cultured ganoderma lucidum with Chinese medicaments and method for preparing cultured ganoderma lucidum health-care product
Iwo et al. Immunostimulating effect of pule (Alstonia scholaris LR Br., Apocynaceae) bark extracts
CN101805763B (en) Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity
CN102008516B (en) Ultrafine powder traditional Chinese medicine for treating tumors
CN106727738A (en) A kind of Phellinus glossy ganoderma powder and preparation method thereof
CN101961367B (en) Chinese medicinal composition for preventing alcoholic liver injury
JPS6212720A (en) Production of aloe reishi
KR101184349B1 (en) Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Bacillus subtilis KCTC 11454BP as an active ingredient, and a preparation method thereof
JPS6212721A (en) Production of shiitake reishi
EA019814B1 (en) Composition useful for the prevention or reduction of the progression of prostate cancer
CN101904499B (en) Method for preparing probiotics and ginkgo pollen oral solution
CN106511915B (en) A kind of compound traditional Chinese medicine composite is inhibiting the application in cutaneous melanoma Lung metastases drug
JP2011184349A (en) Frequent urination-ameliorating composition, healthy food and blood flow-ameliorating composition
Jones Reishi mushroom: Ancient medicine in modern times
CN109527583A (en) The new application of Morchella esculenta (L.) Pers sporophore polypeptide
CN102078600B (en) Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same
EP2090315A1 (en) Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, HIV, AIDS and autoimmune diseases
CN104055969B (en) A kind of pharmaceutical composition with antiobesity action
CN101979003A (en) Antitumor traditional Chinese medicine
KR20030082619A (en) Compositions for improving immune activity
CN107970437A (en) Cordyceps sinensis gram oncogene peptide
Figlas et al. MEDICINAL MUSHROOM REISHI (GANODERMA LUCIDUM). MAIN TOXICITY AND ALLERGENICITY STUDIES. DOSAGE, POSOLOGY AND SIDE EFFECTS.
JPH11228440A (en) Medicament such as anticancer agent or immunostimulator and health food/drink
KR101184355B1 (en) Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Cordyceps militaris KCTC 11455BP as an active ingredient, and a preparation method thereof
US20040146588A1 (en) Composition for adaptive immune system optimization and method therefor